Pulmonary function tests as outcomes for systemic sclerosis interstitial lung disease

Interstitial lung disease (ILD) is the leading cause of morbidity and mortality in systemic sclerosis (SSc). We performed a systematic review to characterise the use and validation of pulmonary function tests (PFTs) as surrogate markers for systemic sclerosis-associated interstitial lung disease (SS...

Descripción completa

Detalles Bibliográficos
Autores principales: Caron, Melissa, Hoa, Sabrina, Hudson, Marie, Schwartzman, Kevin, Steele, Russell
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2018
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488607/
https://www.ncbi.nlm.nih.gov/pubmed/29769294
http://dx.doi.org/10.1183/16000617.0102-2017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488607/
https://www.ncbi.nlm.nih.gov/pubmed/29769294
http://dx.doi.org/10.1183/16000617.0102-2017

Ejemplares similares